Author

Sarah Regimont

University of Liège

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:eQTL / molecular QTL mapping· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex Kvasz· 1 shared Alice MayeriD· 1 shared Anne Catherine Moreau· 1 shared Benoit Servais· 1 shared Cathérine ReenaersiD· 1 shared Catherine Van KemsekeiD· 1 shared Edouard J. LouisiD· 1 shared Émilie Detry· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alex Kvasz

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrated cell type-specific analysis of blood and gut identifies matching eQTL for 140 IBD risk loci and entrectinib as possible repurposing candidate.

Hélène Perée, В. А. Петров, Yumie Tokunaga, Alex Kvasz, Sophie Vieujean, Sarah Regimont, Myriam Mni, Marie Wéry, Samira Azarzar, Sophie Jacques, Nicolas Fouillien, Latifa Karim, Manon Deckers, Émilie Detry, Alice Mayer, , Souad Rahmouni

The paper identifies 140 IBD risk loci with matching eQTL in blood and gut tissues and suggests entrectinib as a potential repurposing drug.

medRxiv · Oct 14, 2024 · PreprintGenetic & Genomic Medicine